Julien Lafrance-Vanasse

Julien Lafrance-Vanasse

Auto-generated profile, based on publicly available information

Julien Lafrance-Vanasse

Life Science Division, 1 Cyclotron Road, Berkeley, CA 94720, USA

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2015 in Progress in Biophysics and Molecular Biology
Verified
Journal Article
Open access
JLJulien Lafrance-Vanasse
Julien Lafrance-Vanasse
GWGareth J. Williams
Gareth J. Williams
JTjohn Tainer
john Tainer
The Mre11-Rad50-Nbs1 (MRN) complex is a dynamic macromolecular machine that acts in the first steps of DNA double strand break repair, and each of its components has intrinsic dynamics and flexibility properties that are directly linked with their functions. As a result, deciphering the functional structural biology of the MRN complex is driving novel and integrated technologies to define the dynamic structural biology of protein machinery interacting with DNA. Rad50 promotes dramatic long-range allostery through its coiled-coil and zinc-hook domains. Its ATPase activity drives dynamic transitions between monomeric and dimeric forms that can be modulated with mutants modifying the ATPase rate to control end joining versus resection activities. The biological functions of Mre11's dual endo- and exonuclease activities in repair pathway choice were enigmatic until recently, when they were unveiled by the development of specific nuclease inhibitors. Mre11 dimer flexibility, which may be regulated in cells to control MRN function, suggests new inhibitor design strategies for cancer intervention. Nbs1 has FHA and BRCT domains to bind multiple interaction partners that further regulate MRN. One of them, CtIP, modulates the Mre11 excision activity for homologous recombination repair. Overall, these combined properties suggest novel therapeutic strategies. Furthermore, they collectively help to explain how MRN regulates DNA repair pathway choice with implications for improving the design and analysis of cancer clinical trials that employ DNA damaging agents or target the DNA damage response.

1 July 2014 in DNA Repair
Verified
Journal Article
Closed access
STSusan E. Tsutakawa
Susan E. Tsutakawa
JLJulien Lafrance-Vanasse
Julien Lafrance-Vanasse
JTjohn Tainer
john Tainer

1 July 2007 in Developmental Biology
Verified
Journal Article
Closed access
ALAurore L'HOnoré
Aurore L'HOnoré
VCVincent Coulon
Vincent Coulon
AMAlexandre Marcil
Alexandre Marcil
MLMélanie Lebel
Mélanie Lebel
JLJulien Lafrance-Vanasse
Julien Lafrance-Vanasse
JDJacques Drouin
Jacques Drouin

12 May 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
GAGai Ayalon
Gai Ayalon
SLSeung-Hye Lee
Seung-Hye Lee
OAOskar Adolfsson
Oskar Adolfsson
CFCorinne Foo-Atkins
Corinne Foo-Atkins
JAJasvinder K. Atwal
Jasvinder K. Atwal
GKGeoffrey A. Kerchner
Geoffrey A. Kerchner
Semorinemab shows beneficial effects in preclinical models and engages tau in a phase 1 study of patients with Alzheimer’s disease.

29 April 2019 in mAbs
Verified
Journal Article
Open access
SCShan Chung
Shan Chung
VNVan Nguyen
Van Nguyen
YLYuwen Linda Lin
Yuwen Linda Lin
JLJulien Lafrance-Vanasse
Julien Lafrance-Vanasse
SSSuzie J. Scales
Suzie J. Scales
ASAn Song
An Song
A cell-based assay employing Madin–Darby canine kidney cells stably expressing human neonatal Fc receptor (FcRn) heavy chain and β2-microglobulin genes was developed to measure transcytosis of monoclonal antibodies (mAbs) under conditions relevant to the FcRn-mediated immunoglobulin G (IgG) salvage pathway. The FcRn-dependent transcytosis assay is modeled to reflect combined effects of nonspecific interactions between mAbs and cells, cellular uptake via pinocytosis, pH-dependent interactions with FcRn, and dynamics of intracellular trafficking and sorting mechanisms. Evaluation of 53 mAbs, including 30 marketed mAb drugs, revealed a notable correlation between the transcytosis readouts and clearance in humans. FcRn was required to promote efficient transcytosis of mAbs and contributed directly to the observed correlation. Furthermore, the transcytosis assay correctly predicted rank order of clearance of glycosylation and Fv charge variants of Fc-containing proteins. These results strongly support the utility of this assay as a cost-effective and animal-sparing screening tool for evaluation of mAb-based drug candidates during lead selection, optimization, and process development for desired pharmacokinetic properties.

1 January 2009 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JLJulien Lafrance-Vanasse
Julien Lafrance-Vanasse
MLMaryse Lefebvre
Maryse Lefebvre
PLPaola Di Lello
Paola Di Lello
JSJurgen Sygusch
Jurgen Sygusch
JOJames G. Omichinski
James G. Omichinski
Bacteria resistant to methylmercury utilize two enzymes (MerA and MerB) to degrade methylmercury to the less toxic elemental mercury. The crucial step is the cleavage of the carbon-mercury bond of methylmercury by the organomercurial lyase (MerB). In this study, we determined high resolution crystal structures of MerB in both the free (1.76-A resolution) and mercury-bound (1.64-A resolution) states. The crystal structure of free MerB is very similar to the NMR structure, but important differences are observed when comparing the two structures. In the crystal structure, an amino-terminal alpha-helix that is not present in the NMR structure makes contact with the core region adjacent to the catalytic site. This interaction between the amino-terminal helix and the core serves to bury the active site of MerB. The crystal structures also provide detailed insights into the mechanism of carbon-mercury bond cleavage by MerB. The structures demonstrate that two conserved cysteines (Cys-96 and Cys-159) play a role in substrate binding, carbon-mercury bond cleavage, and controlled product (ionic mercury) release. In addition, the structures establish that an aspartic acid (Asp-99) in the active site plays a crucial role in the proton transfer step required for the cleavage of the carbon-mercury bond. These findings are an important step in understanding the mechanism of carbon-mercury bond cleavage by MerB.